Johns Hopkins ABX Guide
Efavirenz
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretroviral agents in adults and pediatric patients at least 3 months old and weighing at least 3.5 kg
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 3, 2019
Citation
Bernice, Fidelia. "Efavirenz." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540183/6/Efavirenz.
Bernice F. Efavirenz. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540183/6/Efavirenz. Accessed December 27, 2024.
Bernice, F. (2019). Efavirenz. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540183/6/Efavirenz
Bernice F. Efavirenz [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 December 27]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540183/6/Efavirenz.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Efavirenz
ID - 540183
A1 - Bernice,Fidelia,Pharm.D.
Y1 - 2019/09/03/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540183/6/Efavirenz
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
